权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Patient Provider Communication Larch Supplement

患者提供者沟通落叶松补充剂

基本信息

批准号：
10830643
负责人：
Karen J Wernli
金额：
$ 10万
依托单位：
KAISER FOUNDATION RESEARCH INSTITUTE
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-07-15 至 2026-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10830643
关键词：
Address Adherence Area Attitude Cessation of life Clinical Communication Continuity of Patient Care Early Diagnosis Early treatment Education Electronic Health Record Equity Fright Future Goals Health Health Benefit Health Technology Health system Healthcare Systems Infrastructure Intervention Interview Larix Malignant neoplasm of lung Medical Methods Multimedia Participant Patients Persons Population Provider Public Health Randomized Research Role Scanning Screening for cancer System Technology Testing Time United States Voice Washington cancer care care delivery digital health digital intervention experience health care delivery health communication health management human centered design improved informant interest loved ones lung cancer screening novel parent grant patient engagement patient oriented patient population patient portal patient response patient-clinician communication pragmatic randomized trial response screening willingness

项目摘要

PROJECT SUMMARY This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA- 23-041. Screening for lung cancer has the potential for a profound public health benefit; however, adherence to lung cancer screening remains low in the United States. Multilevel digital health interventions, which target patients, clinicians, and healthcare systems, offer a promising solution to address the gaps in lung cancer screening. Digital health can improve patient-centeredness in interventions by increasing patient reach, accessibility, and understanding through education. We propose to leverage the unique infrastructure of the Larch trial (R01CA262015) via the proposed supplemental study in response to NOT-CA-23-041. The proposed supplemental study is within the scope of parent grant, a pragmatic randomized trial testing patient- centered interventions to promote adherence to repeat lung cancer screening. One intervention being tested is the Patient Voices Video, an educational video for patients, which is delivered via Kaiser Permanente Washington patient portal after a negative lung cancer screening scan. The supplemental study goal is to define and understand which populations would be responsive to digital health communication for lung cancer screening using the Patient Voice Video as a ‘use case’. More importantly, our findings will also identify which patient populations are not reached via digital health messaging, which can influence future focal areas to increase equity in digital health messaging for cancer screening. For this supplemental study, our aims are: 1) Evaluate patient-, provider- and system-factors associated with Kaiser Permanente Washington patient portal access and engagement with video messaging in the portal; and 2) Understand patient engagement with Patient Voices Video and attitudes toward multimedia screening interventions with key informant interviews. The proposed mixed-methods supplement study will improve our understanding of patient engagement with digital health interventions, with high potential to inform future research to improve lung cancer screening and increase equity in cancer care delivery.

项目摘要本申请是为了响应被标识为NOT-CA的特别利益通知（NOSI）而提交的- 23-041.肺癌筛查有可能带来深远的公共卫生益处;然而，肺癌筛查在美国仍然很低。多层次数字健康干预措施，患者，临床医生和医疗保健系统，提供了一个有前途的解决方案，以解决肺癌的差距筛选数字健康可以通过增加患者覆盖范围，可及性和通过教育的理解。我们建议利用落叶松试验（R 01 CA 262015）通过拟定的补充研究响应NOT-CA-23-041。的拟议的补充研究是在父母补助金的范围内，一个务实的随机试验测试病人- 集中干预，以促进对重复肺癌筛查的依从性。正在测试的一种干预措施是患者之声视频，一个针对患者的教育视频，通过Kaiser Permanente提供肺癌筛查扫描阴性后的华盛顿患者门户网站。补充研究的目标是定义并了解哪些人群会对肺癌数字健康传播做出反应使用患者语音视频作为“用例”进行筛查。更重要的是，我们的研究结果还将确定患者群体无法通过数字健康信息传递，这可能会影响未来的重点领域，提高癌症筛查数字健康信息的公平性。对于这项补充研究，我们的目标是：1）评估与Kaiser Permanente华盛顿患者门户相关的患者、提供者和系统因素访问门户网站中的视频消息并与之互动;以及2）了解患者与病人的声音视频和态度多媒体筛查干预与关键线人访谈。拟议的混合方法补充研究将提高我们对患者参与的理解，数字健康干预措施，具有很大的潜力，为未来的研究提供信息，以改善肺癌筛查，提高癌症护理提供的公平性。